EarningsBXPHARMA
BXPHARMA Earnings Update
Announcement summary
- What happened
- BXPHARMA published a corporate disclosure on 29 January 2018. Read the full announcement for details.
- Company
- Beximco Pharmaceuticals PLC.
- Announcement published
Original announcement
(Q2 Un-audited): EPS was Tk. 1.66 for October-December, 2017 as against Tk. 1.47 for October-December, 2016; EPS was Tk. 3.25 for July-December, 2017 as against Tk. 2.74 for July-December, 2016. NOCFPS was Tk. 3.14 for July-December, 2017 as against Tk. 2.56 for July-December, 2016. NAV per share was Tk. 63.77 as on December 31, 2017 and Tk. 59.07 as on December 31, 2016.
Source & verification
- Source
- Published company disclosure
- Published through
- Dhaka Stock Exchange
- Announcement ID
- 616acef05a6b00004005d770
- Original publication
- Last verified by BullBD
- Translation
- BullBD
More news from BXPHARMA
Financial information is provided for general reference only and may be revised by the company. BullBD is not the official DSE website. Not investment advice.